Plasma β-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke

Background: Cerebral amyloid angiopathy (CAA) is one of the main causes of intracerebral hemorrhage (ICH) in the elderly. Objective: To analyze beta-amyloid (A beta) species in plasma in order to uncover biological markers that may contribute to improve the diagnosis of CAA in life. Methods: We determined the level of A beta(1-40), A beta(N-40), A beta(1-42) and A beta(N-42) in plasma of CAA-related ICH patients (n = 29) and healthy controls (n = 21) using xMAP (R) technology. Hemorrhages were identified and classified using a CT scan and brain MRI. Patients were clinically classified as probable or possible CAA according to the Boston criteria. Results: We found that plasma full-length A beta(1-42) and truncated fragments A beta(N-42) were higher in probable CAA patients than in controls (p < 0.001 and p = 0.046, respectively), and full-length A beta(1-40) was selectively elevated in probable CAA compared to possible cases (p = 0.015) and controls (p = 0.005). In addition, plasma A beta(N-42) levels were also higher in patients that presented multiple lobar macrohemorrhages compared to patients that had one symptomatic hemorrhagic event (p = 0.022), indicating that a certain degree of CAA severity is necessary to show increased A beta fragments in peripheral circulation. Conclusion: Our results suggest that specific A beta fragments in plasma might be considered as potential biomarkers for the diagnosis of CAA. Copyright (C) 2012 S. Karger AG, Basel